CMS’ Phurrough Stresses Need For Continuous Data Collection
This article was originally published in The Gray Sheet
Executive Summary
Citing safety issues that might only materialize after "technology is diffused to a larger population," Steve Phurrough, Director of the CMS Coverage and Analysis Group, urges device makers to continue to gather critical data on their products long after they receive FDA approval and enter the commercial market